Ketamine Therapy Cost: At-Home vs Clinic vs Spravato (2026)

Ketamine has gone from a hospital anesthetic to one of the most-searched depression treatments in the country, and the price you pay depends almost entirely on how you get it. The same molecule can cost $129 a month as a daily at-home subscription or $700 a session in a clinic chair. Below is an honest breakdown of every format, what is bundled into each price, and the safety and evidence context you need before spending a dollar.

The Four Ways to Get Ketamine Therapy

Ketamine for mood is delivered four main ways, and they are not interchangeable on price, supervision, or regulatory status:

• At-home oral ketamine — telehealth programs ship sublingual tablets/troches you take at home after a clinician screening. Cheapest tier. Off-label for depression.
• In-clinic IV infusion — a slow intravenous drip under monitoring at a ketamine clinic. The original off-label model; mid-to-high price.
• In-clinic IM injection — an intramuscular shot, usually a bit cheaper than IV, also off-label.
• Spravato (esketamine) — a nasal spray given under supervision at a REMS-certified clinic. The only FDA-approved form for depression, and the one insurance is most likely to cover.

Cost Comparison by Format

The figures below are estimates drawn from published provider pricing and cost guides (Mindbloom, Joyous, and a clinic cost comparison from Lumin Health), not live quotes. Doses, monitoring, and location move the number, and many providers run promotions. Use this to set expectations, then confirm the current price on the provider's own page.

The pattern: at-home oral is the budget tier, in-clinic IV/IM is the mid tier, and Spravato is the most expensive at retail but potentially the cheapest out-of-pocket once insurance applies. The right comparison is not list price — it is your all-in cost after coverage, doses, and any monitoring fees.

At-Home: Mindbloom vs Joyous

The two best-known at-home telehealth ketamine brands take opposite approaches, which is why their pricing looks so different.

Mindbloom — guided, higher-dose sessions

• Multi-session programs: a 6-session program around $1,290 (~$215/session), 12-session around $2,220 (~$185/session), 18-session around $2,970 (~$165/session), billed in monthly installments (estimates)
• Each program bundles clinician consults, sessions with a trained guide, integration support, and a mobile app
• Does not bill insurance, but can provide a superbill to submit for possible out-of-network reimbursement; HSA/FSA generally accepted
• Off-label use of oral ketamine for depression and anxiety

Joyous — low-dose daily subscription

• Subscription pricing from about $129/month (with a longer commitment) or about $159/month on a flexible no-commitment plan (estimates)
• Low daily dose model with text-based check-ins and asynchronous clinician oversight via the app
• Insurance not accepted; HSA/FSA accepted
• Off-label use; designed as an ongoing maintenance subscription rather than a fixed course

In-Clinic IV, IM & Spravato

If you want in-person medical monitoring, you are looking at a clinic. The US now has well over a thousand ketamine clinics, from independent practices to national brands; coverage and quality vary widely, so vet any clinic carefully.

• IV infusion: roughly $400-$700 per session (some clinics quote up to $800). A standard induction is about 6 infusions over two to three weeks, then optional monthly boosters. Off-label and rarely covered.
• IM injection: often $300-$600 per session — typically a bit cheaper than IV. Also off-label and not covered.
• Spravato (esketamine): roughly $590-$1,000+ per session at retail, given as a nasal spray under supervision at a REMS-certified clinic. Because it is FDA-approved, insurance usually applies, dropping many patients to $10-$125 per session.

On the clinic side, brands you may encounter include national ketamine-assisted therapy chains such as Field Trip Health and infusion-clinic chains like Revitalist, alongside hospital-affiliated programs (for example, Northwestern Medicine runs a ketamine infusion program). Spravato is offered at REMS-certified psychiatric clinics nationwide. Always confirm the clinician's credentials, monitoring protocol, and the all-in price before booking — the NPR-reported "ketamine economy" has expanded faster than regulation, so quality is not uniform.

What the Price Actually Includes

Two quotes at the same dollar figure can include very different things. Before you compare, check what is bundled:

Insurance, HSA/FSA & Superbills

This is where the FDA-approval line matters most for your wallet:

• Spravato is the covered option. Because it is FDA-approved for treatment-resistant depression, Medicare and most major commercial plans cover it when you meet criteria, frequently leaving a copay around $10-$125 per session. Manufacturer assistance can lower eligible commercial patients further.
• IV, IM, and at-home oral are usually cash-pay. Off-label depression use means most insurers will not reimburse the treatment itself.
• HSA/FSA can help. At-home programs like Mindbloom and Joyous generally accept HSA/FSA, effectively discounting the cost by your tax rate.
• Superbills are not a guarantee. Mindbloom can provide an itemized superbill you may submit for possible out-of-network reimbursement, but whether your plan pays is up to the plan.

The practical move: if you may qualify for treatment-resistant depression, price Spravato through your insurance first — it can be the cheapest out-of-pocket path despite the highest retail price. Confirm coverage with your plan before assuming a treatment qualifies.

What the Evidence Shows

Ketamine is studied for its rapid antidepressant effect, which is what makes it different from standard antidepressants that take weeks. In reviewed trials, improvement on depression rating scales has been observed within hours of an infusion, and one review reported that a large share of treatment-resistant patients met response criteria at 24 hours. That said:

• Effects can be fast but are often not durable without repeated dosing or maintenance — part of why protocols use induction courses plus boosters.
• Only Spravato (esketamine) has cleared FDA review for depression; the evidence base for various at-home oral protocols is thinner and still developing.
• Researchers continue to flag that long-term effects are not fully characterized, including questions about repeated off-label use.

In short: promising and fast-acting in studied populations, but not a guaranteed or permanent fix, and the strength of evidence varies by format. No treatment described here guarantees an outcome.

Safety & What to Know First

Ketamine is a real medication with real considerations. A balanced view before you spend:

• Dissociation and short-term effects. Reviewed side effects include dissociative symptoms, transient blood-pressure increases, and confusion or agitation around the time of dosing — reasons monitoring matters.
• Misuse and dependence risk. Long-term safety is still being studied; ketamine has abuse potential, which is part of why Spravato carries a REMS and is given under supervision.
• Screening is not optional. Certain conditions (for example uncontrolled hypertension or some psychiatric histories) can make ketamine inappropriate. A proper medical evaluation should precede any program.
• At-home means less supervision. The lower price of at-home programs partly reflects self-administration; that is a trade-off to weigh with a clinician, not just a discount.
• Clinic quality varies. The number of clinics has grown faster than oversight, so verify credentials and protocols rather than choosing on price.

A simple decision framework

1. Talk to a licensed clinician about whether ketamine therapy is appropriate for you at all
2. If you may have treatment-resistant depression, price FDA-approved Spravato through your insurance first
3. If paying cash, compare the all-in program cost (not per-session) across at-home and in-clinic options
4. Weigh supervision and convenience, not just price, and verify provider credentials before booking

Related guides

Ketamine is one piece of the cash-pay mental-health landscape. For lower-cost talk-therapy and psychiatry options, and for adjacent telehealth care, see:

• Online therapy platforms: our BetterHelp vs Talkspace vs Brightside comparison covers therapy and psychiatry pricing
• Specialized telehealth programs: see how affordable online care is structured in our CIRS telehealth treatment guide
• More cash-pay services: browse the full health guides library